{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:21:06Z","timestamp":1788283266894,"version":"build-2803163510"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>Hematopoietic stem cell transplant (HSCT) is the only curative treatment modality for Wiskott-Aldrich syndrome. Haploidentical HSCT with posttransplant cyclophosphamide (PTCy) is an upcoming option in children with nonmalignant conditions. However, only few cases have been reported for Wiskott-Aldrich syndrome HSCT with PTCy approach. Here we report a 4-year-old boy, treated successfully by haploidentical HSCT with myeloablative conditioning (busulfan, fludarabine, and thiotepa) and PTCy. Posttransplant chimerism was fully donor. Of 13 cases (current case and other 12 published cases) 10 are alive and disease free after haploidentical HSCT with PTCy. Haploidentical HSCT with PTCy using myeloablative conditioning is feasible and safe.<\/jats:p>","DOI":"10.1097\/mph.0000000000001841","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T11:44:47Z","timestamp":1590579887000},"page":"e230-e233","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide in Wiskott-Aldrich Syndrome With Myeloablative Conditioning"],"prefix":"10.1097","volume":"43","author":[{"given":"Anil","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutomi","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya P.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,5,26]]},"reference":[{"key":"R1-20260901","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1182\/blood-2008-12-115253","article-title":"Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome","volume":"113","author":"Bosticardo","year":"2009","journal-title":"Blood"},{"key":"R2-20260901","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.iac.2010.02.001","article-title":"Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: advances in biology and future directions for treatment","volume":"30","author":"Pai","year":"2010","journal-title":"Immunol Allergy Clin North Am"},{"key":"R3-20260901","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12026-009-8139-0","article-title":"High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation","volume":"47","author":"Luznik","year":"2010","journal-title":"Immunol Res"},{"key":"R4-20260901","first-page":"51","article-title":"Acute GvHD prophylaxis with posttransplant cyclophosphamide after hematopoietic stem cell transplantation (HSCT) for non-malignant disorders","volume":"17","author":"Bykova","year":"2018","journal-title":"Pediatr Hematol\/Oncol Immuno"},{"key":"R5-20260901","doi-asserted-by":"crossref","first-page":"1417.e1","DOI":"10.1016\/j.jaci.2017.07.008","article-title":"T-cell receptor \u03b1\u03b2(+) and CD19(+) cell-depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency","volume":"141","author":"Shah","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"R6-20260901","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2019.01.030","article-title":"New graft manipulation strategies improve the outcome of mismatched stem cell transplantation in children with primary immunodeficiencies","volume":"144","author":"Elfeky","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"R7-20260901","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26783","article-title":"Reduced-toxicity alternate-donor stem cell transplantation with posttransplant cyclophosphamide for primary immunodeficiency disorders","author":"Rastogi","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R8-20260901","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1097\/MPH.0000000000000959","article-title":"Successful reduced intensity conditioning alternate donor stem cell transplant for Wiskott-Aldrich syndrome","volume":"39","author":"Thakkar","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"R9-20260901","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/bmt.2017.25","article-title":"Successful HLA haploidentical HSCT with post-transplant cyclophosphamide in Wiskott-Aldrich syndrome","volume":"52","author":"Kreetapirom","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"R10-20260901","doi-asserted-by":"crossref","first-page":"e27092","DOI":"10.1002\/pbc.27092","article-title":"Posttransplant cyclophosphamide for haploidentical stem cell transplantation in children with Wiskott-Aldrich syndrome","volume":"65","author":"Yue","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20260901","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10875-019-00600-z","article-title":"Haploidentical stem cell transplantation with post-transplant cyclophosphamide for primary immune deficiency disorders in children: challenges and outcome from a tertiary care center in South India","volume":"39","author":"Uppuluri","year":"2019","journal-title":"J Clin Immunol"},{"key":"R12-20260901","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood-2010-11-319376","article-title":"Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study","volume":"118","author":"Moratto","year":"2011","journal-title":"Blood"},{"key":"R13-20260901","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.V97.6.1598","article-title":"Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program","volume":"97","author":"Filipovich","year":"2001","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000001841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:04:26Z","timestamp":1788282266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000001841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,26]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001841","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,26]]},"assertion":[{"value":"2019-07-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}